Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Soda and Milk Study

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
СъстояниеЗавършен
Спонсори
UCSF Benioff Children's Hospital Oakland
Сътрудници
Almond Board of California

Ключови думи

Резюме

Much attention has been directed at the unhealthy effects of sugar-sweetened beverages (SSBs), as an increase in their consumption has paralleled the rise obesity rates. In adults, SSBs have been shown to promote ectopic fat storage and raise plasma triglycerides compared to equivalent amounts of semi-skim (1.5%) milk, water, or diet beverages. Replacement of soda with milk had the added benefit of also reducing systolic blood pressure. While several studies have investigated the effects of SSBs on weight gain in children, no published studies have investigated their effects on lipid and lipoprotein risk factors under isocaloric conditions in metabolically at-risk adolescents, who are among the greatest consumers of SSBs. The main objective of this study is to test whether isocaloric replacement of soda with reduced fat milk will significantly improve atherogenic dyslipidemia, blood pressure, insulin sensitivity, and liver function in overweight and obese adolescents who are habitual soda consumers. The investigators will test this in a 8 week randomized two period crossover trial in 30 overweight and obese adolescent males who are self-reported habitual consumers of SSBs. Participants will consume energy equivalent amounts of SSB (24oz soda containing high fructose corn syrup per day), and reduced fat milk (2% milk fat) for 3 weeks each, in random order, separated by a 2-week washout. Anthropometrics, blood pressure, and blood samples will be collected at screen and at the end of each intervention period. Plasma measurements will include LDL peak particle diameter; lipoprotein subclass concentrations; triglycerides; total, LDL, and HDL-cholesterol; apolipoproteins; glucose, insulin, and insulin resistance; high sensitivity C-reactive protein; uric acid; and liver enzymes.

Дати

Последна проверка: 09/30/2017
Първо изпратено: 03/19/2014
Очаквано записване подадено: 03/20/2014
Първо публикувано: 03/23/2014
Изпратена последна актуализация: 10/30/2017
Последна актуализация публикувана: 11/05/2017
Действителна начална дата на проучването: 03/31/2014
Приблизителна дата на първично завършване: 08/31/2016
Очаквана дата на завършване на проучването: 04/30/2017

Състояние или заболяване

Obesity
Dyslipidemia

Интервенция / лечение

Dietary Supplement: Reduced Fat Milk

Dietary Supplement: Sugar Sweetened Soda

Фаза

-

Групи за ръце

ArmИнтервенция / лечение
Experimental: Reduced Fat Milk
20 oz. reduced fat (2%) milk per day
Dietary Supplement: Reduced Fat Milk
Subjects will be provided with and instructed to consume the equivalent of 20oz. reduced fat milk per day for 3 weeks
Experimental: Sugar Sweetened Soda
24oz. soda per day
Dietary Supplement: Sugar Sweetened Soda
Subjects will be provided with and instructed to consume 2 cans (24oz) of sugar sweetened soda per day for 3 weeks

Критерии за допустимост

Възрасти, отговарящи на условията за проучване 13 Years Да се 13 Years
Полове, допустими за проучванеMale
Приема здрави доброволциДа
Критерии

Inclusion Criteria:

- Males, age 13-18

- Tanner stage ≥ 2

- Self reported sugar sweetened beverage intake 24oz to 60oz per day

- Self reported milk intake ≤16 oz. per day

- BMI 85-99 percentile for age

- Tolerant to milk

Exclusion Criteria:

- History or diagnosis of hypertension or taking blood pressure lowering medication

- History or diagnosis of diabetes, HbA1c ≥ 6.5% or fasting glucose ≥ 126 mg/dl

- Fasting triglyceride > 300 mg/dl

- On lipid lowering or diabetes medication

Резултат

Първични изходни мерки

1. LDL peak particle diameter [3 weeks]

Вторични изходни мерки

1. Plasma triglycerides [3 weeks]

2. LDL-cholesterol [3 weeks]

3. HDL-cholesterol [3 weeks]

4. Blood pressure [3 weeks]

Systolic and diastolic

5. LDL subclass concentrations [3 weeks]

6. Apolipoprotein B [3 weeks]

7. Apolipoprotein AI [3 weeks]

8. Apolipoprotein CIII [3 weeks]

Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge